AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8576672 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined thoracic and balanced anesthesia (Group 2)
Number of subjects: 47
Study 2363300 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature sensitive mutant ts1B
Number of subjects: 0
Study 2363300 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild-type RS virus
Number of subjects: 0
Study 2363300 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature sensitive mutants (other than ts1B)
Number of subjects: 0
Study 24271 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipoxizin
Number of subjects: 12
Study 24271 — intervention group
Group type: COMPARATOR
Intervention: Hexoprenalin
Number of subjects: 12
Study 12572377 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishen Jiedu Recipe (YSJDR) in addition to low-protein diet and blood pressure controlling therapy
Number of subjects: 45
Study 12572377 — intervention group
Group type: COMPARATOR
Intervention: Low-protein diet and blood pressure controlling therapy only
Number of subjects: 45
Study 30110358 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction Competencies with Children for Teachers (ICC-T)
Number of subjects: 644
Study 26673391 — intervention group
Group type: EXPERIMENTAL
Intervention: H7N9 live attenuated influenza vaccine
Number of subjects: 40
Study 26673391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 25555099 — intervention group
Group type: EXPERIMENTAL
Intervention: WelTel text messaging intervention
Number of subjects: 20
Study 22367325 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-port access (TPA)
Number of subjects: 63
Study 22367325 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 63
Study 20307166 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking intervention (eight-session individually administered trial)
Number of subjects: 247
Study 18584479 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy extract supplementation (3 Evestrel capsules, providing a total of 112.5 mg isoflavones aglycone eq/day) for 3 days before prostate surgery
Number of subjects: 12
Study 18584479 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy extract supplementation
Number of subjects: 12
Study 16875160 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE1 (Prostavasin) infusion at a dose of 0.02 mg/kg b.m./min
Number of subjects: 54
Study 16875160 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PGE1 infusion)
Number of subjects: 54
Study 12800417 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus Injection (AI) 30 ml (equivalent to 60 g crude drug) administered intravenously once a day for 20 days
Number of subjects: 62
Study 12800417 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerine injection 10 mg administered intravenously once a day for 20 days (Control group)
Number of subjects: 62
Study 10806603 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-852 (1 microgram/kg/min for 1 hour)
Number of subjects: 0
Study 10806603 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-852 (0.44 microgram/kg/min for 4 hours)
Number of subjects: 0
Study 8872850 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine GITS
Number of subjects: 6592
Study 8872850 — intervention group
Group type: COMPARATOR
Intervention: Co-amilozide (thiazide diuretic)
Number of subjects: 6592
Study 1510426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 400 mg i.v.
Number of subjects: 12
Study 1510426 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin oral doses (500 mg and 750 mg)
Number of subjects: 12
Study 1510426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin i.v. dosing
Number of subjects: 12
Study 1510426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 12
Study 1510426 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (both routes)
Number of subjects: 12
Study 6682776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cis-diamminedichloroplatinum (II) (CDDP) at various doses (20 mg/m2, 25-50 mg/m2, 70-120 mg/m2)
Number of subjects: 48
Study 6682776 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid infusion of a single high dose of CDDP
Number of subjects: 48
Study 6682776 — intervention group
Group type: COMPARATOR
Intervention: Daily low dose of CDDP for 5 days
Number of subjects: 48
Study 6682776 — intervention group
Group type: COMPARATOR
Intervention: Single low dose of CDDP
Number of subjects: 48
Study 30450972 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry heat treatment (fluidotherapy)
Number of subjects: 93
Study 30450972 — intervention group
Group type: COMPARATOR
Intervention: Control group (joint protection and exercise program)
Number of subjects: 93
Study 30483718 — intervention group
Group type: EXPERIMENTAL
Intervention: Proplan virtual software teaching method
Number of subjects: 100
Study 30483718 — intervention group
Group type: COMPARATOR
Intervention: Traditional orthognathic surgery teaching method
Number of subjects: 100
Study 27656053 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam and Diclofenac Potassium (pre-medication)
Number of subjects: 198
Study 27656053 — intervention group
Group type: EXPERIMENTAL
Intervention: Gow-Gates technique with pre-medication
Number of subjects: 198
Study 27656053 — intervention group
Group type: COMPARATOR
Intervention: Control group (without pre-medication)
Number of subjects: 198
Study 24864502 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneregel
Number of subjects: 66
Study 24864502 — intervention group
Group type: EXPERIMENTAL
Intervention: Solcoseryl Eye Gel
Number of subjects: 66
Study 24864502 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneregel and low-viscosity artificial tears
Number of subjects: 66
Study 24864502 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial tears (preservative-free, low and high viscosity)
Number of subjects: 66
Study 23146641 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization with platelet-rich plasma (PRP)
Number of subjects: 20
Study 23146641 — intervention group
Group type: COMPARATOR
Intervention: Revascularization without platelet-rich plasma (PRP)
Number of subjects: 20
Study 20057344 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (IVTA) injection plus panretinal photocoagulation (PRP) and macular photocoagulation (MPC)
Number of subjects: 23
Study 20057344 — intervention group
Group type: COMPARATOR
Intervention: PRP and MPC (control)
Number of subjects: 23
Study 17347809 — intervention group
Group type: EXPERIMENTAL
Intervention: Full macular translocation (FMT)
Number of subjects: 50
Study 17347809 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 50
Study 16123680 — intervention group
Group type: EXPERIMENTAL
Intervention: pegylated interferon alpha‐2b 1.5 microg/kg/wk and ribavirin 800‐1200 mg/d for 24 weeks
Number of subjects: 50
Study 16123680 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 50
Study 12469988 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (5 mg and 10 mg once daily)
Number of subjects: 1920
Study 12469988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1920
Study 10427675 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-directed action (reaching for preferred food)
Number of subjects: 14
Study 10427675 — intervention group
Group type: COMPARATOR
Intervention: Rote exercise (reaching to a spatial location)
Number of subjects: 14
Study 10427675 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural context (reaching to pick up the receiver of an active telephone)
Number of subjects: 14
Study 10427675 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial context (reaching to a detached receiver)
Number of subjects: 14
Study 10427675 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated context (reaching for a stick)
Number of subjects: 14
Study 7579555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron, 5 mg o.d. plus dexamethasone, 12 mg i.v. on day 1 followed by 4 mg orally b.i.d. on days 2‐5
Number of subjects: 126
Study 7579555 — intervention group
Group type: COMPARATOR
Intervention: Tropisetron, 5 mg o.d.
Number of subjects: 126
Study 7579555 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron plus dexamethasone
Number of subjects: 126
Study 2181110 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronal scaling, root planing, modified Widman surgery, and flap with osseous resectional surgery
Number of subjects: 82
Study 6106611 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 27
Study 6106611 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 27
Study 6106611 — intervention group
Group type: COMPARATOR
Intervention: Chloral hydrate 250 mg
Number of subjects: 27
Study 6106611 — intervention group
Group type: COMPARATOR
Intervention: Chloral hydrate 500 mg
Number of subjects: 27
Study 6106611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 31277678 — intervention group
Group type: EXPERIMENTAL
Intervention: Local distribution acupoint (LA) group
Number of subjects: 108
Study 31277678 — intervention group
Group type: EXPERIMENTAL
Intervention: Local-distal acupoint (LDA) group
Number of subjects: 108
Study 31277678 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list (WL) group
Number of subjects: 108
Study 29030524 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe sleep QI intervention
Number of subjects: 8
Study 27321790 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (10 µg/kg bolus followed by infusion at a rate of 0.1 µg/kg/min for 24 hours)
Number of subjects: 40
Study 27321790 — intervention group
Group type: COMPARATOR
Intervention: Milrinone (50 µg/kg bolus followed by infusion at a rate of 0.5 µg/kg/min for 24 hours)
Number of subjects: 40
Study 25118146 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-determination youth intervention (GSD-Y)
Number of subjects: 71
Study 25118146 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 71
Study 21791141 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS)
Number of subjects: 291
Study 19161479 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside Teaching (BT) followed by Computer-Based Learning (CBL)
Number of subjects: 28
Study 19161479 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Based Learning (CBL) followed by Bedside Teaching (BT)
Number of subjects: 28
Study 19161479 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire responses
Number of subjects: 28
Study 17156836 — intervention group
Group type: EXPERIMENTAL
Intervention: walking routes
Number of subjects: 64
Study 17156836 — intervention group
Group type: EXPERIMENTAL
Intervention: walking in tasks
Number of subjects: 64
Study 17156836 — intervention group
Group type: COMPARATOR
Intervention: control (maintain normal behaviour)
Number of subjects: 64
Study 15831514 — intervention group
Group type: EXPERIMENTAL
Intervention: recombinant FSH (rFSH)
Number of subjects: 85
Study 11977638 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifostin (treatment group A)
Number of subjects: 193
Study 10080444 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal oxygen applied by nasal prongs
Number of subjects: 0
Study 10080444 — intervention group
Group type: COMPARATOR
Intervention: Comparable controls (not specified)
Number of subjects: 0
Study 8714736 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning force microscopy
Number of subjects: 0
Study 2035790 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth-to-mouth breathing
Number of subjects: 17
Study 2035790 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple ventilation device
Number of subjects: 17
Study 2035790 — intervention group
Group type: COMPARATOR
Intervention: Automatic ventilators
Number of subjects: 17
Study 7268356 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg sulfinpyrazone with sodium load
Number of subjects: 18
Study 7268356 — intervention group
Group type: COMPARATOR
Intervention: Control (no sulfinpyrazone)
Number of subjects: 18
Study 30635007 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 160
Study 30635007 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 160
Study 30635007 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS combined with opioid drugs
Number of subjects: 160
Study 30635007 — intervention group
Group type: COMPARATOR
Intervention: Opioid drugs
Number of subjects: 160
Study 30461602 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous propofol anesthesia
Number of subjects: 186
Study 30461602 — intervention group
Group type: COMPARATOR
Intervention: Inhalational sevoflurane anesthesia
Number of subjects: 186
Study 27884128 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored multifaceted dietary intervention
Number of subjects: 220
Study 27884128 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral probiotic treatment (Lactobacillus rhamnosus GG and Bifidobacterium lactis BB12 at a dose of 7 × 10^9 colony-forming units one per day until birth)
Number of subjects: 220
Study 27884128 — intervention group
Group type: COMPARATOR
Intervention: Routine dietary advice
Number of subjects: 220
Study 27884128 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 220
Study 24859367 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic intramedullary nail (EIN)
Number of subjects: 66
Study 24859367 — intervention group
Group type: COMPARATOR
Intervention: Precontoured dynamic compression plate
Number of subjects: 66
Study 22648385 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding (BRF) in SGA infants
Number of subjects: 174
Study 22648385 — intervention group
Group type: COMPARATOR
Intervention: Formula-feeding (FOF) in SGA infants (standard formula - FOF1)
Number of subjects: 174
Study 22648385 — intervention group
Group type: COMPARATOR
Intervention: Formula-feeding (FOF) in SGA infants (protein-rich formula - FOF2)
Number of subjects: 174
Study 22648385 — intervention group
Group type: COMPARATOR
Intervention: Breast-feeding (BRF) in AGA infants
Number of subjects: 174
Study 18835506 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (0.5 g/kg/day)
Number of subjects: 78
Study 18835506 — intervention group
Group type: COMPARATOR
Intervention: Isonitrogenous, isocaloric, isovolemic nutritional solution
Number of subjects: 78
Study 18835506 — intervention group
Group type: COMPARATOR
Intervention: Physiological NaCl 0.9%
Number of subjects: 78
Study 17635245 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.07% cetylpyridinium chloride (CPC) mouth rinse (Crest Pro‐Health)
Number of subjects: 151
Study 17635245 — intervention group
Group type: COMPARATOR
Intervention: Essential oils (EO) mouth rinse (Listerine)
Number of subjects: 151
Study 15234680 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand grasp neuroprosthesis with natural sensory feedback
Number of subjects: 11
Study 15234680 — intervention group
Group type: COMPARATOR
Intervention: Hand grasp neuroprosthesis without natural sensory feedback
Number of subjects: 11
Study 12034156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg TID in addition to diuretics, digoxin, enalapril and carvedilol
Number of subjects: 59
Study 12034156 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (diuretics, digoxin, enalapril and carvedilol)
Number of subjects: 59
Study 12034156 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 59
Study 12029907 — intervention group
Group type: EXPERIMENTAL
Intervention: Early discharge with axillary drains in situ
Number of subjects: 0
Study 12029907 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital stay
Number of subjects: 0
Study 9562007 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (100 mg 2-h infusion)
Number of subjects: 66
Study 9562007 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (1.5 million IU over 2 h)
Number of subjects: 66
Study 9562007 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 66
Study 7942481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transaortic RF ablation (n = 54)
Number of subjects: 73
Study 7942481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transseptal RF ablation (n = 28)
Number of subjects: 73
Study 7942481 — intervention group
Group type: EXPERIMENTAL
Intervention: Total RF ablation success
Number of subjects: 73
Study 7942481 — intervention group
Group type: EXPERIMENTAL
Intervention: Transseptal puncture/long sheath method (n = 24)
Number of subjects: 73
Study 7942481 — intervention group
Group type: COMPARATOR
Intervention: Transseptal group
Number of subjects: 73
Study 7942481 — intervention group
Group type: COMPARATOR
Intervention: Transaortic group
Number of subjects: 73
Study 3204147 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 30 mg administered 12 h before hCG injection and 48 h before oocyte capture
Number of subjects: 40
Study 3204147 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 40
Study 1565806 — intervention group
Group type: EXPERIMENTAL
Intervention: Information about a married mother client
Number of subjects: 83
Study 1565806 — intervention group
Group type: COMPARATOR
Intervention: Information about an unmarried mother client
Number of subjects: 83
Study 1565806 — intervention group
Group type: COMPARATOR
Intervention: Predictions of patients' behaviors and verbal responses
Number of subjects: 83
Study 329406 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU of calciferol daily for 8 months
Number of subjects: 0
Study 29752009 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 PUFAs (2 g daily, 8 weeks)
Number of subjects: 31
Study 29607864 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Fillapex
Number of subjects: 45
Study 29607864 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoREZ
Number of subjects: 45
Study 29607864 — intervention group
Group type: EXPERIMENTAL
Intervention: AH26
Number of subjects: 45
Study 27620862 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-week sensory motor training program
Number of subjects: 22
Study 27620862 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued soccer practice sessions)
Number of subjects: 22
Study 25137844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture-anesthetic composite anesthesia (AACA)
Number of subjects: 93
Study 25137844 — intervention group
Group type: COMPARATOR
Intervention: Intravenous anesthesia (sufentanil combined propofol)
Number of subjects: 93
Study 25137844 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with intravenous anesthesia (sufentanil, propofol combined with acupuncture)
Number of subjects: 93
Study 22207450 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure with standard of care
Number of subjects: 15
Study 22207450 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 15
Study 19067708 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 200
Study 19067708 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 200
Study 19067708 — intervention group
Group type: COMPARATOR
Intervention: Pimecrolimus cream 1% and Vehicle (control)
Number of subjects: 200
Study 17985507 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized psychoeducational diabetes uncertainty management intervention (DM‐UMI) delivered via telephone for four weeks
Number of subjects: 68
Study 17985507 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 68
Study 16027437 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with alpha‐tocopherol (400 IU/d) and beta‐carotene (30 mg/d)
Number of subjects: 540
Study 16027437 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with alpha‐tocopherol and beta‐carotene
Number of subjects: 540
Study 12004847 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 5‐FU (600 mg/m2 24‐hour infusion for five days, then 600 mg/m2 IV once a week) and IFN (5 MU subcutaneously three times a week for six months)
Number of subjects: 322
Study 12004847 — intervention group
Group type: COMPARATOR
Intervention: Combination of leucovorin (20 mg/m2 rapid intravenous injection) and 5‐FU (425 mg/m2 IV days 1‐5 every 28 days for six cycles)
Number of subjects: 322
Study 10457120 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg u.i.d.) plus flunisolide (two 25 microg puffs per nostril morning and night)
Number of subjects: 30
Study 10457120 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus flunisolide (two 25 microg puffs per nostril morning and night)
Number of subjects: 30
Study 7799030 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF/IFN/M (tumor necrosis factor, interferon gamma, and melphalan)
Number of subjects: 19
Study 7799030 — intervention group
Group type: COMPARATOR
Intervention: M alone (melphalan)
Number of subjects: 19
Study 7799030 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF/IFN/M
Number of subjects: 19
Study 2205326 — intervention group
Group type: EXPERIMENTAL
Intervention: Endosonography
Number of subjects: 37
Study 2205326 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 37
Study 2205326 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 37
Study 2205326 — intervention group
Group type: COMPARATOR
Intervention: Examination Under Anaesthesia (EUA)
Number of subjects: 37
Study 371643 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 8
Study 371643 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 8
Study 31662539 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expandable metal stent positioning (Group 1, 16 patients)
Number of subjects: 33
Study 31662539 — intervention group
Group type: COMPARATOR
Intervention: Primary tumor resection (Group 2, 17 patients)
Number of subjects: 33
Study 28249612 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin chemo‐irradiation with SIB-IMRT, escalating total dose to the GTV up to 80.5 Gy. Chemotherapy planned either in the 1st and 5th week (cisplatin 20 mg/m2/d d 1-5 and d 29-33) or weekly (cisplatin 40 mg/m2/d) during RT. RT delivered as SIB with total doses of 80.5 Gy/70.0 Gy/56.0 Gy with 2.3 Gy/2.0 Gy and 1.6 Gy.
Number of subjects: 100